Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Croucher

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|July 23, 1998
Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitorP G Hargreaves, F Wang, J Antcliff, et al.
British Journal of Haematology|June 3, 1998
Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significanceH I Sati, J F Apperley, M Greaves, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytesN McKie, T Edwards, D J Dallas, et al.
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Bisphosphonates--mechanisms of action in multiple myelomaC M Shipman, M J Rogers, K Vanderkerken, et al.
Basic Life Sciences|January 1, 1990
The relationship between spinal trabecular bone mineral content and iliac crest trabecular bone volumeC D Wright, E O Crawley, W D Evans, et al.
Calcified Tissue International|March 1, 1990
The relationship between spinal trabecular bone mineral content and iliac crest trabecular bone volumeC D Wright, E O Crawley, W D Evans, et al.
British Journal of Haematology|November 25, 2000
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myelomaC M Shipman, K Vanderkerken, M J Rogers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
The pharmacology of bisphosphonates and new insights into their mechanisms of actionR G Russell, M J Rogers, J C Frith, et al.
Leukemia|July 28, 2007
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transferN Rabin, C Kyriakou, L Coulton, et al.
Immunity|December 13, 2003
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerinA J Ashcroft, S M Cruickshank, P I Croucher, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|July 23, 1998
Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitorP G Hargreaves, F Wang, J Antcliff, et al.
British Journal of Haematology|June 3, 1998
Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significanceH I Sati, J F Apperley, M Greaves, et al.
Biochemical and Biophysical Research Communications|January 13, 1997
Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytesN McKie, T Edwards, D J Dallas, et al.
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Bisphosphonates--mechanisms of action in multiple myelomaC M Shipman, M J Rogers, K Vanderkerken, et al.
Basic Life Sciences|January 1, 1990
The relationship between spinal trabecular bone mineral content and iliac crest trabecular bone volumeC D Wright, E O Crawley, W D Evans, et al.
Calcified Tissue International|March 1, 1990
The relationship between spinal trabecular bone mineral content and iliac crest trabecular bone volumeC D Wright, E O Crawley, W D Evans, et al.
British Journal of Haematology|November 25, 2000
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myelomaC M Shipman, K Vanderkerken, M J Rogers, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 6, 1999
The pharmacology of bisphosphonates and new insights into their mechanisms of actionR G Russell, M J Rogers, J C Frith, et al.
Leukemia|July 28, 2007
A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transferN Rabin, C Kyriakou, L Coulton, et al.
Immunity|December 13, 2003
Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerinA J Ashcroft, S M Cruickshank, P I Croucher, et al.
Pageof 6